Comparison of Immunofluorescence and Desmoglein Enzyme-linked Immunosorbent Assay in the Diagnosis of Pemphigus: A Prospective, Cross-sectional Study in a Tertiary Care Hospital

Background: Pemphigus is an acquired immunobullous disorder in which antibodies are directed against epidermal cadherins. Despite the commercial availability and less cost of enzyme-linked immunosorbent assays (ELISAs) to detect antidesmoglein 1 (Dsg1) and anti-Dsg3, immunofluorescence is still widely used for confirmation of diagnosis. Aims: (1) To compare the usefulness of indirect immunofluorescence (IIF) and ELISA tests in the diagnosis of pemphigus. (2) To find the clinical correlation between the tests and severity of the disease. Materials and Methods: Sixty-one patients (27 women and 34 men, age distribution from 20 to 75) were clinically diagnosed as pemphigus (pemphigus foliaceus - 11, pemphigus vulgaris - 50) and were recruited for the study. IIF and Dsg ELISA were performed and the findings were compared with each other and with the pemphigus area activity score. Data were entered in SPSS and were analyzed using Kruskal–Wallis test. Results: There was a moderate positive correlation between the cutaneous score and Dsg1 titer, and mucosal score and Dsg3 titer. The titer of IIF showed statistically significant positive correlation with the cutaneous score but not the mucosal score. Dsg ELISA showed higher sensitivity (90.2%) than IIF (75.4%) in the diagnosis of pemphigus. Conclusions: Dsg ELISA is a more sensitive method than IIF and shows more correlation with the disease severity.

[1]  Xuejun Zhu,et al.  [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris]. , 2011, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[2]  S. Grover.  SCORING SYSTEMS IN PEMPHIGUS , 2011, Indian journal of dermatology.

[3]  Z. Naraghi,et al.  Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris. , 2009, Iranian journal of allergy, asthma, and immunology.

[4]  Raghavendra Rao,et al.  Techniques of immunofluorescence and their significance. , 2008, Indian journal of dermatology, venereology and leprology.

[5]  H. Mortazavi,et al.  CORRELATION OF PEMPHIGUS VULGARIS ANTIBODY TITERS BY INDIRECT IMMUNOFLUORESCENCE WITH ACTIVITY OF DISEASE BASED ON PEMPHIGUS AREA AND ACTIVITY SCORE (PAAS) , 2008 .

[6]  D. Zillikens,et al.  Enzyme‐linked immunosorbent assay using multimers of the 16th non‐collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies , 2007, Experimental dermatology.

[7]  Yung-Ting Chang,et al.  Using Desmoglein 1 and 3 Enzyme‐linked Immunosorbent Assay as an Adjunct Diagnostic Tool for Pemphigus , 2007, Journal of the Chinese Medical Association : JCMA.

[8]  R. Jain,et al.  Study of desmoglein 1 and 3 antibody levels in relation to disease severity in Indian patients with pemphigus. , 2006, Indian journal of dermatology, venereology and leprology.

[9]  R. Bergman,et al.  A comparison of anti‐desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris , 2005, International journal of dermatology.

[10]  Michelle A. Pipitone,et al.  Immunobullous diseases. , 2005, Journal of the American Academy of Dermatology.

[11]  B. Adams,et al.  Immunofluorescence in dermatology. , 2001, Journal of the American Academy of Dermatology.

[12]  P. Seed,et al.  The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels , 2001, The British journal of dermatology.

[13]  P. Lenz,et al.  Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. , 1999, Archives of dermatology.

[14]  T. Nishikawa,et al.  The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. , 1999, Journal of the American Academy of Dermatology.

[15]  P. Amerio,et al.  Direct Immunofluorescence Diagnosis of Pemphigus without Biopsy , 1998, Journal of cutaneous medicine and surgery.

[16]  Claire L. Haycox,et al.  Rook's Textbook of Dermatology: CD-ROM , 1997 .

[17]  T. Nishikawa,et al.  Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. , 1997, Journal of immunology.

[18]  K. V. Ratnam,et al.  Pemphigus in remission: value of negative direct immunofluorescence in management. , 1994, Journal of the American Academy of Dermatology.

[19]  M. Black,et al.  Correlation of circulating intercellular antibody titres in pemphigus with disease activity , 1981, Clinical and experimental dermatology.

[20]  H. Mescon,et al.  Comparison of different epithelial substrates useful for indirect immunofluorescence testing of sera from patients with active pemphigus. , 1979, The Journal of investigative dermatology.

[21]  W. F. Lever,et al.  Correlation of antibodies in skin and serum with disease severity in pemphigus. , 1979, Archives of dermatology.

[22]  Uses for immunofluorescence tests of skin and sera. Utilization of immunofluorescence in the diagnosis of bullous diseases, lupus erythematosus, and certain other dermatoses. , 1975, Archives of dermatology.